Author | Rachael Zimlich, RN, BSN


Payers Should Take Action on Rising NSCLC Costs

November 29, 2019

A new report outlines the sharp cost increase associated with a NSCLC drug’s move from second-line to first-line treatment, and suggests payers work with manufacturers to address treatment pricing.

Chemotherapy Remains Significant for Cancer Treatment

November 29, 2019

Chemotherapy may be the “boomer” to millennial-esque new cancer treatments, but there is a reason the old standard became that way, and isn’t likely to be replaced anytime soon.

Personalized Treatments Could Increase Value of Cancer Care

November 25, 2019

There are a lot of ideas about ways to increase the value of cancer care, but personalized treatments may be the most significant and immediate.  

Collaboration Key to a Holistic Model of Cancer Care

November 25, 2019

A holistic approach provides value and creates plans that support the wide-ranging needs of cancer patients and their families.